Mergers and acquisitions – Page 14
-
Business
Lumara splits and sells to AMAG and Perrigo
Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
-
BusinessMerck KGaA to buy Sigma–Aldrich
$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development
-
BusinessBayer to sever polymer arm
German chemical giant’s exit from the materials world will help fund its crop and healthcare ambitions
-
Business
Eastman snaps up Taminco for $2.8bn
Purchase will strengthen Eastman in niche markets and offers cost savings
-
BusinessRoche to buy InterMune for respiratory boost
$8.3bn deal gives Roche a leading position in pulmonary fibrosis
-
Business
Clinical collaborations drive cancer immunotherapy
Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
-
Business
Illumina targets cancer diagnostics
Sequencing will improve tests and speed up clinical trials processes for big pharma partners
-
Business
Sanofi snaps up inhaled insulin licence
Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
-
Business
AstraZeneca stocks respiratory and cancer pipelines
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
-
Business
Bruker winds down underperforming instrument lines
Stand-alone gas chromatographs and certain mass spectrometry products to be sold off
-
Business
Reckitt Benckiser to spin out US pharma arm
Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products
-
BusinessPharma firms rush to escape US tax shackles
AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries
-
Business
Albemarle buys into lithium with Rockwood merger
$6.2 billion deal capitalises on battery market growth
-
Business
ADM to buy food ingredients specialist Wild Flavors
€2.3bn deal gets ADM into rapidly-growing area of naturally-sourced flavourings
-
Business
Ineos takes full control of Styrolution
€1.1bn deal sees BASF complete its planned exit from styrenics joint venture
-
Business
Genentech to buy breast cancer specialist Seragon
$1.7bn deal for hormone receptor-destroying drug pipeline
-
PodcastChemistry World podcast - July 2014
We speak to artist Briony Marshall and art detective Warren Warren about the more artistic sides of chemistry
-
Business
PPG to buy Mexican paints firm Comex
$2.3bn deal expands US firm’s footprint in Central America
-
Business
Affymax folds after drug withdrawal
Unexplained allergic reactions to anaemia drug prompt firm to dissolve
-
Business
Shire fends off AbbVie takeover bid
Board says deal undervalues the company and its growth potential